These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19034996)

  • 21. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
    Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
    Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichotillomania in Attention-Deficit/Hyperactivity Disorder Under Methylphenidate Treatment.
    Kara T; Akaltun İ
    J Clin Psychopharmacol; 2017 Aug; 37(4):484. PubMed ID: 28492426
    [No Abstract]   [Full Text] [Related]  

  • 23. Bipolar disorder and attention-deficit/hyperactivity disorder in children and adolescents.
    Giedd JN
    J Clin Psychiatry; 2000; 61 Suppl 9():31-4. PubMed ID: 10826658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malnutrition in children with DAMP?].
    Andersen LL
    Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776
    [No Abstract]   [Full Text] [Related]  

  • 25. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.
    Ghanizadeh A
    Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C
    Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
    [No Abstract]   [Full Text] [Related]  

  • 27. Cmap ADHD and comorbid aggression algorithm.
    Sharp BW
    J Am Acad Child Adolesc Psychiatry; 2007 Jan; 46(1):1. PubMed ID: 17195721
    [No Abstract]   [Full Text] [Related]  

  • 28. Methylphenidate (Ritalin) use and abuse.
    Crutchley A; Temlett JA
    S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.
    Ross RG
    Am J Psychiatry; 2006 Jul; 163(7):1149-52. PubMed ID: 16816217
    [No Abstract]   [Full Text] [Related]  

  • 30. ADD and soft signs.
    Foodman A; McPhillips K
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):841-2. PubMed ID: 8768341
    [No Abstract]   [Full Text] [Related]  

  • 31. OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
    Marchant BK; Reimherr FW; Halls C; Williams ED; Strong RE
    Ann Clin Psychiatry; 2010 Aug; 22(3):196-204. PubMed ID: 20680193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder.
    Biederman J; Spencer T
    J Atten Disord; 2002; 6 Suppl 1():S101-7. PubMed ID: 12685524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.
    Rapoport JL; Inoff-Germain G
    J Atten Disord; 2002; 6 Suppl 1():S57-60. PubMed ID: 12685519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.
    Baptista-Neto L; Dodds A; Rao S; Whitney J; Torres A; Gonzalez-Heydrich J
    Expert Opin Investig Drugs; 2008 Jan; 17(1):77-84. PubMed ID: 18095920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylphenidate euphoria.
    Corrigall R; Ford T
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
    [No Abstract]   [Full Text] [Related]  

  • 37. WITHDRAWN: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2016 May; (5):CD005041. PubMed ID: 27228176
    [No Abstract]   [Full Text] [Related]  

  • 38. [The practice and problem of therapeutic agents for AD/HD].
    Tanaka H; Miyajima T
    No To Hattatsu; 2010 May; 42(3):213-6. PubMed ID: 23858580
    [No Abstract]   [Full Text] [Related]  

  • 39. Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder.
    Hamrin V; Bailey K
    J Child Adolesc Psychopharmacol; 2001; 11(3):301-9. PubMed ID: 11642481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylphenidate associated vitiligo in a child: A case report.
    Guler Aksu G; Akdere P; Toros F
    Asia Pac Psychiatry; 2019 Sep; 11(3):e12351. PubMed ID: 30821429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.